Affiliation:
1. Stroke Center, Department of Neurology, the First Hospital of Jilin University, Chang Chun, Jilin 130021, China
2. Neuroscience Research Center, Department of Neurology, the First Hospital of Jilin University, Chang Chun, Jilin 130021, China
Abstract
Abstract
Neurological diseases are a major health concern, and brain injury is a typical pathological process in various neurological disorders. Different biomarkers in the blood or the cerebrospinal fluid are associated with specific physiological and pathological processes. They are vital in identifying, diagnosing, and treating brain injuries. In this review, we described biomarkers for neuronal cell body injury (neuron-specific enolase, ubiquitin C-terminal hydrolase-L1, αII-spectrin), axonal injury (neurofilament proteins, tau), astrocyte injury (S100β, glial fibrillary acidic protein), demyelination (myelin basic protein), autoantibodies, and other emerging biomarkers (extracellular vesicles, microRNAs). We aimed to summarize the applications of these biomarkers and their related interests and limits in the diagnosis and prognosis for neurological diseases, including traumatic brain injury, status epilepticus, stroke, Alzheimer’s disease, and infection. In addition, a reasonable outlook for brain injury biomarkers as ideal detection tools for neurological diseases is presented.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference82 articles.
1. The global burden of neurological disorders: Translating evidence into policy;Feigin;Lancet Neurol,2020
2. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity;Kadry;Fluids Barriers CNS,2020
3. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β;Iliff;Sci Transl Med,2012
4. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells;Marangos;Annu Rev Neurosci,1987
5. New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection;Haque;Brain Sci,2018